Anticonvulsant activity of ester- and amide-type lipid conjugates of glycine and N-benzyloxycarbonylglycine

European Journal of Pharmaceutical Sciences

Volumn 4, Issue 3, 1996, Pages 159-166

  Lambert, Didier M ^a   Scriba, Gerhard K E ^b   Poupaert, Jacques H ^a   Dumont, Pierre ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Anticonvulsant; Glycine; Glycine receptor; Lipid conjugates; N Benzyloxycarbonylglycine; NMDA receptor

Indexed keywords

AMIDE; DRUG CARRIER; ESTER DERIVATIVE; GLYCINE DERIVATIVE; GLYCINE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; STRYCHNINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ELECTRIC SHOCK; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029989038     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/0928-0987(95)00044-5     Document Type: Article

References (28)

1. Aprison, M.H. (1990) The discovery of the neurotransmitter role of glycine. In Ottersen, O.P. and Storm-Mathisen, J. (Eds.) Glycine Neurotransmission. Wiley, New York, NY, pp. 1-23.
2. Bentley, P. H. and McCrae, N.J. (1970) An efficient synthesis of symmetrical 1,3-diglycerides. J. Org. Chem. 35, 2082-2083.
3. Betz, H. (1992) Structure and function of inhibitory glycine receptors. Q. Rev. Biophys. 25, 381-394.
4. 3H]dichlorokynurenic acid. J. Pharm. Pharmacol. 44, 812-816.
5. Goncalves, J.C.S. (1990) Propharmacomolecules sous forme de triacylglycerols: synthese et evaluation des proprietes vectrices. Ph.D. Thesis, School of Pharmacy, Catholic University of Louvain, Brussels, Belgium.
6. Halsey, M.J., Little, H.J. and Wardley-Smith, B. (1989) Systemically administered glycine protects against styrchnine convulsions but not the behavioural effects of high pressure in mice. J. Physiol. 408, 431-441.
7. Howe, J.R. and Malkin, T. (1951) An x-ray and thermal examination of the glycerides. Part XI. 1,2-Diglycerides and further observations on 1,3-diglycerides. J. Chem. Soc., 2663-2667.
8. Jacob, J.N., Shashoua, V.E., Campbell, A. and Baldessarini (1985) γ-Aminobutyric acid esters. 2. Synthesis, brain uptake, and pharmacological properties of lipid esters of γ-aminobutyric acid. J. Med. Chem. 28, 106-110.
9. Jacob, J.N., Hesse, J.W. and Shashoua, V.E. (1987) γ-aminobutyric acid esters. 3. Synthesis, brain uptake, and pharmacological properties of C-18 glyceryl lipid esters of GABA with varying degree of unsaturation. J. Med. Chem. 30, 1573-1576.
10. Jacob, J.N., Hesse, J.W. and Shashoua, V.E. (1990) Synthesis, brain uptake, and pharmacological properties of a glyceryl lipid containing GABA and the GABA-T inhibitor γ-vinyl-GABA. J. Med. Chem. 33, 733-736.
11. Kemp, J.A. and Leeson, P.D. (1992) The glycine site of the NMDA receptor. Five years on. Trends Protein Sci. 14, 20-25.
12. Lambert, D.M., Neuvens, L., Mergen, F., Gallez, B. Poupaert, J.H., Ghysel-Burton, J., Maloteaux, J.M. and Dumont, P. (1993) 1,3-diacylaminopropan-2-ols and corresponding 2-acyl derivatives as drug carriers: unexpected pharmacological properties. J. Pharm. Pharmacol. 45, 186-191.
13. Lambert, D.M., Poupaert, J.H., Maloteaux, J.M. and Dumont, P. (1994) Anticonvulsant activities of N-benzyloxycarbonylglycine after parenteral administration. Neuroreport 5, 777-780.
14. Lambert, D.M., Scriba, G.K.E., Gallez, B., Poupaert, J.H. and Dumont, P. (1995a) Glyceride conjugates as drug carriers. Curr. Med. Chem. 5, 376-391.
15. Lambert, D.M., Mergen, F., Berens, C., Poupaert, J.H. and Dumont, P. (1995b) Synthesis and pharmacological properties of 2-[S-acetylthiorphan]-1,3-diacylaminopropan-2-ol derivatives as chimeric lipid drug carriers containing an enkephalinase inhibitor. Pharm. Res. 12, 187-191.
16. Lapin, I.P. (1981) Antagonism of glycine to seizures induced by L-kynurenine, quinolinic acid and strychnine in mice. Eur. J. Pharmacol. 71, 495-498.
17. Litchfield, J.T. and Wilcoxon, F.J. (1949) A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96, 99-113.
18. Marvizon, J.C.G., Vazquez, J., Calvo, M.G., Ruiz-Gomez, A., Valdivieso, F. and Benavides, J. (1986) The glycine receptor: pharmacological studies and mathematical modeling of the allosteric interaction between the glycine and strychnine binding sites. Mol. Pharmacol. 30, 590-597.
19. Mergen, F., Lambert, D.M., Goncalves-Saraiva, J.C., Poupaert, J.H. and Dumont, P. (1991a) Antiepileptic activity of 1,3-dihexadecanoylamino-2-valproyl-propan-2-ol, a prodrug of valproic acid endowed with a tropism for the central nervous system. J. Pharm. Pharmacol. 43, 815-816.
20. Mergen, F., Lambert, D.M., Poupaert, J. H., Bidaine, A. and Dumont, P. (1991b) Synthesis of 1,3-diacylamino-2-propanols and corresponding 2 acyl derivatives as amide isosteres of natural lipids. Chem. Phys. Lipids 59, 267-272.
21. Peterson, S.L., Trzeciakowski, J.P., Frye G.D. and Adams, H.R. (1990) Potentiation by glycine of anticonvulsant drugs in maximal electroshock seizures in rats. Neuropharmacology 29, 399-409.
22. Peterson, S.L. (1991) Glycine potentiation of anticonvulsant drugs in pentylenetetrazol seizures in rats. Brain Res. Bull. 26, 43-47.
23. Sarhan, S., Kolb, M. and Seiler, N. (1984) The amplification of the anticonvulsant effect of vinyl GABA (4-aminohexenoic acid) by esters of glycine. Arzneim.-Forsch. 34, 687-690.
24. Seiler, N. and Sarhan S. (1984) Synergistic anticonvulsant effects of a GABA-T inhibitors and glycine. Naunyn-Schmiedeberg's Arch. Pharmacol. 15, 367-369.
25. Swinyard, E. A., Brown, W. C. and Goodman, L. S. (1952) Comparative assays of antiepileptic drugs in mice and rats. J. Pharmacol. Exp. Ther. 106, 319-330.
26. Toth, E., Lajtha, A., Sarhan, S. and Seiler, N. (1983) Anticonvulsant effects of some inhibitory neurotransmitter amino acids. Neurochem. Res. 8, 291-302.
27. Vamvakides, A. (1986) Synthese et evaluation pharmacologique du lineolamide de glycine. Ann. Pharm. Franc. 44, 144-155.
28. Van Dorsser, W., Barris, D., Cordi, A. and Roba, J. (1983) Anticonvulsant activity of milacemide. Arch. Int. Pharmacodyn. Ther. 266, 239-249.